On the background of yesterday price hike for 42 of their most prescribed drugs (including Cosentyx )
http://www.biopharmadive.com/news/pfizer-novartis-amgen-2019-drug-price-hikes/546877/
The PBS is taking care that those syringes don't hurt the wallet:
http://www.facebook.com/7NewsMelbourne/videos/326577114662198/
Results from BTX1308 phase1 are due later this quarter, another potential 'disruptor' for a well guarded money making source?
Looking like BOT is going to surprise the market, IMO.
BOT, page-76
-
- There are more pages in this discussion • 84 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
0.020(5.97%) |
Mkt cap ! $707.4M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 36.0¢ | 33.3¢ | $2.622M | 7.530M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 106888 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.5¢ | 462320 | 5 |
View Market Depth
| Last trade - 16.10pm 26/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
